Thomas Doetschman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas Doetschman has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Ilona Ormsby
Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
5 shared publicationsGregory P. Boivin
Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
4 shared publicationsRamireddy Bommireddy
Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
4 shared publicationsMoying Yin
Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267
3 shared publicationsGeorge F. Babcock
Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
2 shared publicationsJohn N. Lorenz
2 shared publications
Latest Publications
- 1 November 2004
- Published by Elsevier in Cellular Immunology
- Vol. 232 (1-2) , 96-104
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFβ1-deficient mice
- 1 November 2004
- Published by Elsevier in Cellular Immunology
- Vol. 232 (1-2) , 96-104
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFβ1-deficient mice
- 1 January 2004
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (1) , 3-9
TGF-β, T-cell tolerance and anti-CD3 therapy
- 1 January 2004
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (1) , 3-9
TGF-β, T-cell tolerance and anti-CD3 therapy
- Open Access
- 1 April 2003
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (7) , 3645-3652
TGFβ1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes
TGFβ1 is a polypeptide growth modulatory and differentiation factor involved in many biological processes including immune homeostasis and self-tolerance. Tgfb1 knockout mice die around weaning age due to severe inflammation in most major organ systems, but the mechanism underlying this disease is not understood. In this study we demonstrate that Tgfb1−/− CD4+CD8+ and CD4+CD8− thymocytes are hyperresponsive to receptor-mediated and receptor-independent mitogenic stimulation. A suboptimal concentration of ionomycin in the presence of PMA fully activates Tgfb1−/− thymocytes, whereas the inhibitors of Ca2+ influx and calcineurin, EGTA and FK506, eliminate the hyperresponsiveness. Hence, the hypersensitivity of Tgfb1−/− thymocytes is due to a lowered threshold for Ca2+-dependent activation. Further, we demonstrate that the hypersensitivity of thymocytes results from the absence of TGFβ1 and not from the inflammatory environment because the thymocytes are hyperresponsive in preinflammatory-stage Tgfb1−/− mice. Our results suggest for the first time that TGFβ1 functions to inhibit aberrant T cell expansion by maintaining intracellular calcium concentration levels low enough to prevent a mitogenic response by Ca2+-independent stimulatory pathways alone. Consequently, TGFβ1 prevents autoimmune disease through a Ca2+ regulatory pathway that maintains the activation threshold above that inducible by self-MHC-TCR interactions.
- 1 April 2003
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (7) , 3645-3652
Open AccessTGFβ1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes
TGFβ1 is a polypeptide growth modulatory and differentiation factor involved in many biological processes including immune homeostasis and self-tolerance. Tgfb1 knockout mice die around weaning age due to severe inflammation in most major organ systems, but the mechanism underlying this disease is not understood. In this study we demonstrate that Tgfb1−/− CD4+CD8+ and CD4+CD8− thymocytes are hyperresponsive to receptor-mediated and receptor-independent mitogenic stimulation. A suboptimal concentration of ionomycin in the presence of PMA fully activates Tgfb1−/− thymocytes, whereas the inhibitors of Ca2+ influx and calcineurin, EGTA and FK506, eliminate the hyperresponsiveness. Hence, the hypersensitivity of Tgfb1−/− thymocytes is due to a lowered threshold for Ca2+-dependent activation. Further, we demonstrate that the hypersensitivity of thymocytes results from the absence of TGFβ1 and not from the inflammatory environment because the thymocytes are hyperresponsive in preinflammatory-stage Tgfb1−/− mice. Our results suggest for the first time that TGFβ1 functions to inhibit aberrant T cell expansion by maintaining intracellular calcium concentration levels low enough to prevent a mitogenic response by Ca2+-independent stimulatory pathways alone. Consequently, TGFβ1 prevents autoimmune disease through a Ca2+ regulatory pathway that maintains the activation threshold above that inducible by self-MHC-TCR interactions.
- Open Access
- 1 January 2001
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 1 (S3) , 146
ROLE OF TRANSFORMING GROWTH FACTOR 1 IN LYMPHOCYTE DEVELOPMENT AND DEATH
- 1 January 2001
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 1 (S3) , 146
Open AccessROLE OF TRANSFORMING GROWTH FACTOR 1 IN LYMPHOCYTE DEVELOPMENT AND DEATH
- 15 September 1999
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (6) , 709-719
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
In vitro, fibroblast growth factor-2 (FGF2) has been implicated in cardiomyocyte growth and reexpression of fetal contractile genes, both markers of hypertrophy. However, its in vivo role in cardiac hypertrophy during pressure overload is not well characterized. Mice with or without FGF2 (Fgf2+/+ and Fgf2–/–, respectively) were subjected to transverse aortic coarctation (AC). Left ventricular (LV) mass and wall thickness were assessed by echocardiography preoperatively and once a week postoperatively for 10 weeks. In vivo LV function during dobutamine stimulation, cardiomyocyte cross-sectional area, and recapitulation of fetal cardiac genes were also measured. AC Fgf2–/– mice develop significantly less hypertrophy (4–24% increase) compared with AC Fgf2+/+ mice (41–52% increase). Cardiomyocyte cross-sectional area is significantly reduced in AC Fgf2–/– mice. Noncoarcted (NC) and AC Fgf2–/– mice have similar β-adrenergic responses, but those of AC Fgf2+/+ mice are blunted. A lack of mitotic growth in both AC Fgf2+/+ and Fgf2–/– hearts indicates a hypertrophic response of cardiomyocytes. Consequently, FGF2 plays a major role in cardiac hypertrophy. Comparison of α- and β-cardiac myosin heavy chain mRNA and protein levels in NC and AC Fgf2+/+ and Fgf2–/– mice indicates that myosin heavy chain composition depends on hemodynamic stress rather than on FGF2 or hypertrophy, and that isoform switching is transcriptionally, not posttranscriptionally, regulated.
- 15 September 1999
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (6) , 709-719
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
In vitro, fibroblast growth factor-2 (FGF2) has been implicated in cardiomyocyte growth and reexpression of fetal contractile genes, both markers of hypertrophy. However, its in vivo role in cardiac hypertrophy during pressure overload is not well characterized. Mice with or without FGF2 (Fgf2+/+ and Fgf2–/–, respectively) were subjected to transverse aortic coarctation (AC). Left ventricular (LV) mass and wall thickness were assessed by echocardiography preoperatively and once a week postoperatively for 10 weeks. In vivo LV function during dobutamine stimulation, cardiomyocyte cross-sectional area, and recapitulation of fetal cardiac genes were also measured. AC Fgf2–/– mice develop significantly less hypertrophy (4–24% increase) compared with AC Fgf2+/+ mice (41–52% increase). Cardiomyocyte cross-sectional area is significantly reduced in AC Fgf2–/– mice. Noncoarcted (NC) and AC Fgf2–/– mice have similar β-adrenergic responses, but those of AC Fgf2+/+ mice are blunted. A lack of mitotic growth in both AC Fgf2+/+ and Fgf2–/– hearts indicates a hypertrophic response of cardiomyocytes. Consequently, FGF2 plays a major role in cardiac hypertrophy. Comparison of α- and β-cardiac myosin heavy chain mRNA and protein levels in NC and AC Fgf2+/+ and Fgf2–/– mice indicates that myosin heavy chain composition depends on hemodynamic stress rather than on FGF2 or hypertrophy, and that isoform switching is transcriptionally, not posttranscriptionally, regulated.
- Open Access
- 1 February 1998
- Published by Springer Nature in Nature Medicine
- Vol. 4 (2) , 201-207
Fibroblast growth factor 2 control of vascular tone
Vascular tone control is essential in blood pressure regulation, shock, ischemia-reperfusion, inflammation, vessel injury/repair, wound healing, temperature regulation, digestion, exercise physiology, and metabolism. Here we show that a well-known growth factor, FCF2, long thought to be involved in many developmental and homeostatic processes, including growth of the tissue layers of vessel walls, functions in vascular tone control. Fgf2 knockout mice are morphologically normal and display decreased vascular smooth muscle contractility, low blood pressure and thrombocytosis. Following intra-arterial mechanical injury, FGF2-deficient vessels undergo a normal hyperplastic response. These results force us to reconsider the function of FGF2 in vascular development and homeostasis in terms of vascular tone control.
- 1 February 1998
- Published by Springer Nature in Nature Medicine
- Vol. 4 (2) , 201-207
Open AccessFibroblast growth factor 2 control of vascular tone
Vascular tone control is essential in blood pressure regulation, shock, ischemia-reperfusion, inflammation, vessel injury/repair, wound healing, temperature regulation, digestion, exercise physiology, and metabolism. Here we show that a well-known growth factor, FCF2, long thought to be involved in many developmental and homeostatic processes, including growth of the tissue layers of vessel walls, functions in vascular tone control. Fgf2 knockout mice are morphologically normal and display decreased vascular smooth muscle contractility, low blood pressure and thrombocytosis. Following intra-arterial mechanical injury, FGF2-deficient vessels undergo a normal hyperplastic response. These results force us to reconsider the function of FGF2 in vascular development and homeostasis in terms of vascular tone control.
- Open Access
- 1 July 1997
- Published by The Company of Biologists in Development
- Vol. 124 (13) , 2659-2670
TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
The growth and differentiation factor transforming growth factor-β2 (TGFβ2) is thought to play important roles in multiple developmental processes. Targeted disruption of the TGF β2 gene was undertaken to determine its essential role in vivo. TGFβ2-null mice exhibit perinatal mortality and a wide range of developmental defects for a single gene disruption. These include cardiac, lung, craniofacial, limb, spinal column, eye, inner ear and urogenital defects. The developmental processes most commonly involved in the affected tissues include epithelial-mesenchymal interac-tions, cell growth, extracellular matrix production and tissue remodeling. In addition, many affected tissues have neural crest-derived components and simulate neural crest deficiencies. There is no phenotypic overlap with TGFβ1- and TGF β3-null mice indicating numerous non-compen-sated functions between the TGFβ isoforms.
- 1 July 1997
- Published by The Company of Biologists in Development
- Vol. 124 (13) , 2659-2670
Open AccessTGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
The growth and differentiation factor transforming growth factor-β2 (TGFβ2) is thought to play important roles in multiple developmental processes. Targeted disruption of the TGF β2 gene was undertaken to determine its essential role in vivo. TGFβ2-null mice exhibit perinatal mortality and a wide range of developmental defects for a single gene disruption. These include cardiac, lung, craniofacial, limb, spinal column, eye, inner ear and urogenital defects. The developmental processes most commonly involved in the affected tissues include epithelial-mesenchymal interac-tions, cell growth, extracellular matrix production and tissue remodeling. In addition, many affected tissues have neural crest-derived components and simulate neural crest deficiencies. There is no phenotypic overlap with TGFβ1- and TGF β3-null mice indicating numerous non-compen-sated functions between the TGFβ isoforms.
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 61
STRAIN DEPENDENCY OF TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-betal) REQUIREMENT FOR PREIMPLANTATION MOUSE DEVELOPMENT. † 352
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 61
STRAIN DEPENDENCY OF TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-betal) REQUIREMENT FOR PREIMPLANTATION MOUSE DEVELOPMENT. † 352